Skip to main content
Year archive

Prism Medico and Pharmacy Ltd. — 2022 filings

All 48 regulatory filings released by Prism Medico and Pharmacy Ltd. (512217) in 2022, sourced directly from the official regulator.

48 Filings
2022 Period
2022 filings (48)
Filing Released Lang
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Equity Shareholders of Prism Medico and Pharmacy Ltd ....
M&A Activity
2022-12-12 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement for the attention of the Equity Shareholders of Prism Medico and Pharmacy ....
M&A Activity
2022-12-05 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulation 3(1), Regulation 4 read with Regulation 15(1) and Regulation ....
Regulatory Filings
2022-11-28 English
With reference to the above captioned subject, it is hereby submitted that due to the inadvertent mistake/oversight, the complete file of the financial results relating to the quarter and ....
Regulatory Filings
2022-11-17 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that theBoard of Directors at their meeting held ....
Regulatory Filings
2022-11-14 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve With reference to ....
Regulatory Filings
2022-11-04 English
This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations ....
Regulatory Filings
2022-10-20 English
With reference to the above captioned subject report on investor complaints for the quarter ended 30th September, 2022 is as follows: Pending at the beginning of the quarter 0 (Zero) Received .
Regulatory Filings
2022-10-20 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of compliance certificate issued by the ....
Regulatory Filings
2022-10-14 English
Scrutinizer''s Report
Regulatory Filings
2022-10-03 English
Pursuant to Regulation 30 (2) of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015, we hereby submit the proceedings of Annual General Meeting held on Friday, ....
Regulatory Filings
2022-10-01 English
Pursuant to Code of Conduct to regulate, monitor and report Trading by Insiders ('Code') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in ....
Regulatory Filings
2022-09-30 English
Dear Sir/Madam, Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Report of the company ....
Regulatory Filings
2022-09-07 English
Dear Sir/Madam, In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Notice of 20th Annual ....
Regulatory Filings
2022-09-06 English
Dear Sir/Madam, This is to inform you that the 20th Annual General Meeting of the members of the company is scheduled to be held on Friday the 30th day of September, 2022 at 04:30 P.M. ....
Regulatory Filings
2022-09-06 English
Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at ....
Regulatory Filings
2022-09-05 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2022 ,inter alia, to consider and approve Dear Sir/Madam, With ....
Regulatory Filings
2022-09-01 English
Dear Sir / Madam, With reference to the above captioned subject, it is hereby submitted that due to the inadvertent mistake/oversight, the financial details relating to the previous ....
Regulatory Filings
2022-08-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2022-08-13 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve Dear Sir/Madam, With ....
Regulatory Filings
2022-08-06 English
Dear Sir / Madam, This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of ....
Regulatory Filings
2022-07-29 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of Compliance certificate issued by the ....
Regulatory Filings
2022-07-20 English
Compliance certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.
Regulatory Filings
2022-07-20 English
Dear Sir/Madam, Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Insiders ('Code') and applicable SEBI Regulations, we would like to inform you that trading window ....
Regulatory Filings
2022-06-30 English
Dear Sir, Enclosed find the Certificate in relation to non-applicability of Secretarial Compliance Report as per Reg 24A of the SEBI Listing Obligations and Disclosure Requirements (LODR) ....
Regulatory Filings
2022-05-28 English
Approval Of Audited Financial Results For The Quarter And Year Ended 31St March, 2022
Regulatory Filings
2022-05-25 English
OUTCOME OF BOARD MEETING
Regulatory Filings
2022-05-25 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve We wish to inform ....
Regulatory Filings
2022-05-17 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 07th May 2022, at 04:00 P.M concluded at ....
Regulatory Filings
2022-05-07 English
This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is ....
Regulatory Filings
2022-04-26 English
Pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company hereby confirms, that there has been ....
Regulatory Filings
2022-04-26 English
Pursuant to the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 issued by SEBI on 'Fund raising by issuance of Debt Securities by Large Entities', we hereby confirm ....
Regulatory Filings
2022-04-18 English
Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby furnish a copy of Compliance Certificate issued by M.R. Chechi & Associates, ....
Regulatory Filings
2022-04-18 English
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby submit a certificate duly signed by Purva Sharegistry (I) Pvt Ltd, Share ....
Regulatory Filings
2022-04-07 English
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby submit a certificate duly signed by Purva Sharegistry (I) Pvt Ltd, Share ....
Regulatory Filings
2022-04-07 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2022-04-06 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, 02nd April 2022 at 03:00 P.M concluded ....
Regulatory Filings
2022-04-02 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, 02nd April 2022 at 03:00 P.M concluded ....
Regulatory Filings
2022-04-02 English
the Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the year ended 31st March, 2022 for all ....
Regulatory Filings
2022-03-31 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper advertisement of Unaudited Financial ....
Regulatory Filings
2022-02-03 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, 01st February 2022 at 04:00 P.M concluded ....
Regulatory Filings
2022-02-01 English
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit voting results of the 01st Extra Ordinary General Meeting ....
Regulatory Filings
2022-01-31 English
We hereby submit Scrutinizer's report of e-voting conducted for the 1st Extra Ordinary General Meeting of the Company on 31st January 2022 at 11.30 a.m..
Regulatory Filings
2022-01-31 English
Pursuant to Regulation 30 (2) of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015, we hereby submit the proceedings of Extraordinary General Meeting held on ....
Regulatory Filings
2022-01-31 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2022-01-25 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper advertisement of Notice of the Extraordinary ...
Regulatory Filings
2022-01-06 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of revised Confirmation Certificate issued ....
Regulatory Filings
2022-01-03 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2022-01-03 English